Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Lakhani

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Australian Health Review : a Publication of the Australian Hospital Association|May 2, 2008
Pathology in education and practice: a time for integration?Robin Mortimer, Sunil Lakhani
Pathology|May 12, 2019
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in AustraliaGelareh Farshid, Michael Bilous, Adrienne Morey, et al.
Oncogene|August 29, 2003
BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiationSuresh Logarajah, Patricia Hunter, Matthew Kraman, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2026
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in AustraliaAndrew Redfern, Elgene Lim, Sunil Lakhani, et al.
American Journal of Human Genetics|March 9, 2010
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation statusJames M Flanagan, Sibylle Cocciardi, Nic Waddell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2003
X-inactivation patch size in human female tissue confounds the assessment of tumor clonalityMarco Novelli, Antonio Cossu, Dahmane Oukrif, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Virchows Archiv : an International Journal of Pathology|November 14, 2023
Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpressionMartina Bradová, Lester D R Thompson, Martin Hyrcza, et al.
Nature Communications|November 25, 2023
Robust mapping of spatiotemporal trajectories and cell-cell interactions in healthy and diseased tissuesDuy Pham, Xiao Tan, Brad Balderson, et al.
Science Translational Medicine|May 29, 2020
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastasesLin Zhang, Jun Yao, Yongkun Wei, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Australian Health Review : a Publication of the Australian Hospital Association|May 2, 2008
Pathology in education and practice: a time for integration?Robin Mortimer, Sunil Lakhani
Pathology|May 12, 2019
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in AustraliaGelareh Farshid, Michael Bilous, Adrienne Morey, et al.
Oncogene|August 29, 2003
BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiationSuresh Logarajah, Patricia Hunter, Matthew Kraman, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2026
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in AustraliaAndrew Redfern, Elgene Lim, Sunil Lakhani, et al.
American Journal of Human Genetics|March 9, 2010
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation statusJames M Flanagan, Sibylle Cocciardi, Nic Waddell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2003
X-inactivation patch size in human female tissue confounds the assessment of tumor clonalityMarco Novelli, Antonio Cossu, Dahmane Oukrif, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Virchows Archiv : an International Journal of Pathology|November 14, 2023
Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpressionMartina Bradová, Lester D R Thompson, Martin Hyrcza, et al.
Nature Communications|November 25, 2023
Robust mapping of spatiotemporal trajectories and cell-cell interactions in healthy and diseased tissuesDuy Pham, Xiao Tan, Brad Balderson, et al.
Science Translational Medicine|May 29, 2020
Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastasesLin Zhang, Jun Yao, Yongkun Wei, et al.
Pageof 3